UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 10-Q


QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2018September 30, 2018


TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to _________


Commission File Number 000-50009


PACIFIC HEALTH CARE ORGANIZATION, INC.

  (Exact name of registrant as specified in its charter)

Utah

87-0285238

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer I.D. No.)

1201 Dove Street, Suite 300

Newport Beach, California

92660

(Address of principal executive offices)

(Zip Code)


(949) 721-8272

(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for any shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.  Yes    No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)   Yes    No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of large“large accelerated filer,,accelerated filer“accelerated filer”, smaller“smaller reporting companycompany” and emerging“emerging growth companycompany” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)     Yes     No


As of MayNovember 14, 2018, the registrant had 3,200,000 shares of common stock, par value $0.001, issued and outstanding.

 



PACIFIC HEALTH CARE ORGANIZATION, INC.

FORM 10-Q

TABLE OF CONTENTS


Page

PART I — FINANCIAL INFORMATION

3

3

4

5

6

9

15

19

15

19

PART II — OTHER INFORMATION

16

20

16

17

20

18

21

 

PART I.   FINANCIAL INFORMATION

Item 1. Financial Information

Pacific Health Care Organization, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

ASSETS 
  March 31,  December 31, 
  2018  2017 
Current Assets      
Cash $6,705,681  $5,815,071 
Accounts receivable, net of allowance of $60,150 and $60,150  663,323   1,041,242 
Deferred tax assets  43,670   43,670 
Prepaid expenses  170,657   166,782 
    Total current assets  7,583,331   7,066,765 
         
Property and Equipment, net        
Computer equipment  366,616   363,627 
Furniture and fixtures  209,778   209,779 
Office equipment  15,595   15,595 
 Total property and equipment  591,989   589,001 
  Less: accumulated depreciation and amortization  (438,368)  (422,024)
Net property and equipment  153,621   166,977 
Other assets  26,788   26,788 
   Total assets $7,763,740  $7,260,530 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY 
  
Current Liabilities 
Accounts payable $23,913  $71,138 
Accrued expenses  250,793   255,205 
Income tax payable  237,691   81,715 
Dividends payable  56,923   56,923 
Unearned revenue  38,689   38,357 
Deferred rent expense  34,072   35,214 
    Total current liabilities  642,081   538,552 
         
Total Liabilities  642,081   538,552 
         
Commitments and Contingencies  -   - 
         
Shareholder’s Equity        
Preferred stock; 5,000,000 shares authorized at $0.001 par value of which 10,000 shares
designated as Series A preferred and 4,000 shares issued and outstanding at March 31, 2018
and December 31, 2017.
  4   4 
Common stock, $0.001 par value, 200,000,000 shares authorized,
3,200,000 shares issued and outstanding
  3,200   3,200 
Additional paid-in capital  1,237,348   1,237,348 
Deferred stock compensation  (811,679)  (811,679)
 Retained earnings  6,692,786   6,293,105 
    Total stockholders’ equity  7,121,659   6,721,978 
         
     Total liabilities and stockholders’ equity $7,763,740  $7,260,530 

ASSETS

        
  

September 30,

2018

  

December 31,

2017

 

Current Assets

        

Cash

 $6,846,162  $5,815,071 

Accounts receivable, net of allowance of $25,150 and $60,150

  985,737   1,041,242 

Deferred tax asset

  43,670   43,670 

Prepaid income tax

  20,692   - 

Prepaid expenses

  190,123   166,782 

   Total current assets

  8,086,384   7,066,765 
         

Property and Equipment, net

        

Computer equipment

  393,904   363,627 

Furniture and fixtures

  215,959   209,779 

Office equipment

  9,556   15,595 

Total property and equipment

  619,419   589,001 

  Less: accumulated depreciation and amortization

  (472,223

)

  (422,024

)

Net property and equipment

  147,196   166,977 

Other assets

  26,788   26,788 

   Total Assets

 $8,260,368  $7,260,530 
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

        
         

Current Liabilities

        

Accounts payable

 $39,857  $71,138 

Accrued expenses

  349,549   255,205 

Credit card payable

  1,647   - 

Income tax payable

  -   81,715 

Deferred rent expense

  28,767   35,214 

Dividend payable

  37,000   56,923 

Unearned revenue

  39,659   38,357 

   Total current liabilities

  496,479   538,552 
         

Total Liabilities

  496,479   538,552 
         

Commitments and Contingencies

  -   - 
         

Stockholders’ Equity 

        

Preferred stock, 5,000,000 shares authorized at $0.001 par value of which 10,000 shares

designated as Series A preferred and 4,000 shares issued and outstanding at September 30, 2018 and December 31, 2017

  4   4 

Common stock, $0.001 par value, 200,000,000 shares authorized, 3,200,000 shares issued and outstanding at September 30, 2018 and December 31, 2017

  3,200   3,200 

Additional paid-in capital

  425,669   1,237,348 

Deferred stock compensation

  -   (811,679

)

Retained earnings

  7,335,016   6,293,105 

   Total stockholders’ equity

  7,763,889   6,721,978 

   Total Liabilities and Stockholders’ Equity

 $8,260,368  $7,260,530 

The accompanying notes are an integral part of these condensed consolidated financial statements.

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

  
For three months ended
March 31,
 
  2018  2017 
Revenues:      
HCO fees $399,442  $302,569 
MPN fees  134,644   138,281 
NCM fees  582,569   587,236 
UR fees  287,021   237,045 
MBR fees  114,039   156,778 
Other  65,594   119,347 
Total revenues  1,583,309   1,541,256 
         
Expenses:        
Depreciation  16,344   19,827 
Bad debt provision  -   (3,250)
Consulting fees  78,814   77,260 
Salaries and wages  491,478   588,657 
Professional fees  77,470   82,084 
Insurance  67,029   87,275 
Outsource service fees  95,881   112,748 
Data maintenance  32,431   34,619 
General and administrative  168,205   161,388 
Total expenses  1,027,652   1,160,608 
         
Income from operations  555,657   380,648 
         
Other expense  -   - 
Total other expense  -   - 
         
Income before taxes   555,657   380,648 
Income tax provision  (155,976)  (158,391)
         
Net income $399,681  $222,257 
         
Basic earnings per share:        
Earnings per share amount $0.12  $0.07 
Basic common shares outstanding  3,200,000   3,200,000 
         
Fully diluted earnings per share:        
Earnings per share amount $0.11  $0.07 
Fully diluted common shares outstanding  3,544,000   3,204,000 

  

For three months ended

September 30,

  

For nine months ended

September 30,

 
  

2018

  

2017

  

2018

  

2017

 
                 

Revenues

                

  HCO fees

 $372,664  $377,923  $1,132,371  $1,041,328 

  MPN fees

  128,113   142,257   393,390   427,228 

  UR fees

  327,744   277,886   914,262   788,229 

  MBR fees

  140,084   147,094   380,293   481,352 

  NCM fees

  624,655   582,544   1,822,826   1,824,121 

  Other

  83,049   73,203   277,993   255,542 

  Total revenues

  1,676,309   1,600,907   4,921,135   4,817,800 
                 

Expenses

                

   Depreciation and amortization

  17,412   19,462   50,199   58,859 

   Bad debt provision

  -   15,750   (35,000

)

  30,500 

   Consulting fees

  91,619   90,079   255,882   246,073 

   Salaries and wages

  644,407   547,963   1,763,235   1,734,321 

   Professional fees

  91,080   109,064   246,293   308,295 

   Insurance

  73,042   79,489   213,242   257,495 

   Outsource service fees

  92,122   146,287   351,962   404,538 

   Data maintenance

  16,661   12,160   65,890   71,261 

   General and administrative

  209,156   162,164   560,928   495,474 

   Total expenses

  1,235,499   1,182,418   3,472,631   3,606,816 
                 

Income from operations

  440,810   418,489   1,448,504   1,210,984 
                 

Income before taxes

  440,810   418,489   1,448,504   1,210,984 

   Income tax provision

  123,734   174,560   406,593   504,318 
                 

   Net income

 $317,076  $243,929  $1,041,911  $706,666 
                 

Basic and fully diluted earnings per share:

                

   Earnings per share amount

 $0.10  $.08  $0.33  $0.22 

   Weighted average common shares outstanding

  3,204,000   3,204,000   3,204,000   3,204,000 

The accompanying notes are an integral part of these condensed consolidated financial statements.

Pacific

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

  
Three Months Ended
March 31,
 
  2018  2017 
Cash flows from operating activities:      
Net income $399,681  $222,257 
Adjustments to reconcile net income to net cash:        
Increase in depreciation and amortization  16,344   19,827 
Changes in operating assets and liabilities        
(Decrease) in bad debt provision  -   (3,250)
Decrease (increase) in accounts receivable  377,919   (286,412)
(Increase) in prepaid expenses  (3,875)  (5,692)
(Decrease) in accounts payable  (47,225)  (53,418)
(Decrease) increase in deferred rent expense  (1,142)  469 
(Decrease) increase in accrued expenses  (4,412)  35,854 
Increase in income tax payable  155,976   158,391 
Increase (decrease) in unearned revenue  332   (932)
Net cash provided in operating activities  893,598   87,094 
         
Cash flows from investing activities:         
Purchase of furniture and office equipment  (2,988)  (5,754)
Net cash used in investing activities  (2,988)  (5,754)
         
Cash flows from financing activities:        
Net cash used in financing activities  -   - 
Increase in cash  890,610   81,340 
         
Cash at beginning of period  5,815,071   5,005,617 
Cash at end of period $6,705,681  $5,086,957 
         
Supplemental cash flow information        
Cash paid for:        
Interest $-  $- 
Income taxes paid $-  $- 

  

Nine Months Ended

September 30,

 
  

2018

  

2017

 

Cash flows from operating activities:

        

Net income

 $1,041,911  $706,666 

Adjustments to reconcile net income to net cash from operations:

        

Depreciation and amortization

  50,199   58,859 

(Decrease) in bad debt provision

  (35,000

)

  (4,000

)

Changes in operating assets and liabilities:

        

Decrease (increase) in accounts receivable

  90,505   (132,139

)

(Increase) in prepaid expenses

  (23,341

)

  (6,088

)

(Increase) in prepaid income tax

  (20,692

)

  - 

(Decrease) in accounts payable

  (31,281

)

  (38,370

)

(Decrease) increase in deferred rent expense

  (6,447

)

  21,873 

Increase in accrued expenses

  94,344   25,536 

Increase in credit card payable

  1,647   - 

(Decrease) in income tax payable

  (81,715

)

  (10,111

)

Increase (decrease) in unearned revenue

  1,302   (985

)

Net cash provided from operating activities

  1,081,432   621,241 
         

Cash flows from investing activities: 

        

Purchase of computer equipment, furniture and office equipment

  (30,418

)

  (13,446

)

Net cash used in investing activities

  (30,418

)

  (13,446

)

         

Cash flows from financing activities:

        

Issuance of cash dividend

  (19,923

)

  - 

Net cash used in financing activities

  (19,923

)

  - 

Increase in cash

  1,031,091   607,795 
         

Cash at beginning of period

  5,815,071   5,005,617 

Cash at end of period

 $6,846,162  $5,613,412 
         

Supplemental cash flow information

        

Cash paid for:

        

Interest

 $-  $- 

Net income taxes paid

 $558,999  $514,429 

The accompanying notes are an integral part of these condensed consolidated financial statements.

Pacific Health Care Organization, Inc.

Notes to Condensed Consolidated Financial Statements

For the ThreeNine Months Ended March 31,September 30, 2018

(Unaudited)

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION


The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”) and in accordance with accounting principles generally accepted in the United States (“GAAP”).  Certain information and footnote disclosures normally included in consolidated financial statements have been condensed or omitted in accordance with GAAP rules and regulations.  The information furnished in these interim condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the condensed consolidated financial statements and the revenues recognized and expenses incurred during the reporting period. These estimates and assumptions affect the Company’s recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. The reasonableness of these estimates and assumptions is evaluated continually based on a combination of historical information and other information that comes to the Company’s attention that may vary its outlook for the future. While management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed consolidated financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its annual report on Form 10-K for the year ended December 31, 2017.  Operating results for the threenine months ended March 31,September 30, 2018, are not necessarily indicative of the results to be expected for the year ending December 31, 2018.


Principles of Consolidation — The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  Intercompany transactions and balances have been eliminated in consolidation.


Basis of AccountingThe Company uses the accrual method of accounting.


Revenue Recognition — In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” Either a retrospective or cumulative effect transition method, referred to as the modified retrospective method, is permitted. The Company adopted Topic 606 on January 1, 2018, using the modified retrospective method. The adoption of Topic 606 had no material impact on the Company’s interim financial statements.


The core principle underlying Topic 606 is that the Company will recognize revenue to represent the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer.


The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The application of the five-step model to revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue.


In general, the Company recognizes revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) the fee is fixed or determinable and (iv) collectability is reasonably assured.  Revenues are generated as services are provided to the customer based on the sales price agreed and collected.  The Company recognizes revenue as the time is worked or as units of production are completed, which is when the revenue is earned and realized.  Labor costs are recognized as the costs are incurred.

6

Pacific Health Care Organization, Inc.

Notes to Condensed Consolidated Financial Statements

For the Nine Months Ended September 30, 2018

(Unaudited)

The Company derives its revenue from the sale of managed care, bill review, utilization review and nurse case management services. These services are billed individually as separate components to our customers. These fees include monthly administration fees, claim network fees, legal support fees, Medicare-set-asideMedicare set-aside fees, lien service fees, workers’ compensation carve-outs, flat rate fees or hourly fees depending on the agreement with the client.


The Company enters into arrangements for bundled managed care which includes various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.

Accounts Receivables and Bad Debt Allowance– In the normal course of business the Company extends credit to its customers on a short-term basis.  Although the credit risk associated with these customers is minimal, the Company routinely reviews its accounts receivable balances and makes provisions for doubtful accounts.  The Company ages its receivables by date of invoice.  Management reviews bad debt reserves quarterly and reserves specific accounts as warranted or sets up a general reserve based on amounts over 90 days past due.  When an account is deemed uncollectible, the Company charges off the receivable against the bad debt reserve.  A considerable amount of judgment is required in assessing the realization of these receivables including the current creditworthiness of each customer and related aging of the past-due balances, including any billing disputes.  In order to assess the collectability of these receivables, the Company performs ongoing credit evaluations of its customers’ financial condition. Through these evaluations, the Company may become aware of a situation where a customer may not be able to meet its financial obligations due to deterioration of its financial viability, credit rating or bankruptcy.  The allowance for doubtful accounts is based on the best information available to the Company and is reevaluated and adjusted as additional information is received.   We evaluate the allowance based on historical write-off experience, the size of the individual customer balances, past-due amounts and the overall national economy.  At March 31,September 30, 2018 and December 31, 2017, our bad debt reserves wereof $25,150 and $60,150, asrespectively, was a general reserve for certain balances over 90 days past due and for accounts that are potentially uncollectible.


The percentages of the amounts due from major customers to total accounts receivable as of March 31,September 30, 2018 and December 31, 2017, are as follows:

  3/31/2018  12/31/2017 
Customer A  27%  35%
Customer B  0%  13%
Customer C  11%  5%

  

9/30/2018

  

12/31/2017

 

Customer A

  28

%

  35

%

Customer B

  12

%

  13

%

Customer C

  11

%

  5

%

Significant Customers - We provide services to insurers, third party administrators, self-administered employers, municipalities and other industries.  We are able to provide our full range of services to virtually any size employer in the state of California.  We are also able to provide UR, MBRutilization review (“UR”), medical bill review (“MBR”) and NCMnurse case management (“NCM”) services outside the state of California. 


During the period ended March 31,September 30, 2018 and 2017, we had twothree customers that accounted for more than 10% of our total sales.  The following table sets forth details regarding the percentage of total sales attributable to our significant customers in the past two years:

  

9/30/2018

  

9/30/2017

 

Customer A

  28

%

  20

%

Customer B

  12

%

  13

%

Customer C

  11

%

  11

%

7

  3/31/2018  3/31/2017 
Customer A  32%  18%
Customer B  11%  7%
Customer C  6%  13%

Pacific Health Care Organization, Inc.

Notes to Condensed Consolidated Financial Statements

For the Nine Months Ended September 30, 2018

(Unaudited)

NOTE 2 - SUBSEQUENT EVENTS


In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and other than disclosed in this Note 2 there are no material subsequent events to report.


As disclosed in the Definitive Information Statement the Company filed with the Commission on March 6, 2018, and mailed to its shareholders by March 14, 2018, during the first quarter of 2018 the Company’s board of directors and majority shareholder approved a four-shares-for-one-share forward split of our outstanding common stock (the “Forward Split”).  The number of authorized shares of the Company’s common stock also increased at the same ratio, from 50,000,000 shares to 200,000,000 shares.  The number of authorized shares of Company preferred stock did not increase.  The Forward Split took effect on April 5, 2018.  As a result of the Forward Split, the number of outstanding shares of Company common stock increased from 800,000 shares to 3,200,000 shares and, consistent with the Articles of Incorporation of the Company, the number of outstanding shares of Series A Preferred Stock increased from 1,000 to 4,000.  As a result of the Forward Split, the number of shares available for issuance under the Company’s 2002 Stock Option Plan (the “2002 Plan”) and the Company’s 2005 Stock Option Plan (the “2005 Plan”), as well as all awards outstanding under those plans also increased at the same four-shares-for-one-share ratio, and the exercise prices of stock options outstanding at the time of the Forward Split were adjusted to reflect the Forward Split.  On April 6, 2018, the day immediately following the effective date of the Forward Split, the Company’s 2018 Equity Incentive Plan (the “2018 Plan”) became effective.
On May 14, 2018, the Company entered into Stock Option Cancellation Agreements (the “Cancellation Agreements”) with certain executive officers, directors and other senior level employees/consultants of the Company, pursuant to which such individuals (the “Optionholder”) agreed to the surrender and cancellation of certain previously granted stock options (the “Cancelled Options”) under the 2002 Plan and the 2005 Plan to purchase 85,000 pre-Forward Split shares (340,000 post-Forward Split shares) of the Company’s common stock.  Under the terms of the Cancellation Agreements, each Optionholder and the Company acknowledged and agreed that the surrender and cancellation of the Cancelled Options was without any expectation on the part of the Optionholder to receive, and without any obligation on the Company to pay or grant, any cash, equity awards or other consideration presently or in the future with respect to the Cancelled Options.  Following the surrender and cancellation of the Cancelled Options there were no awards outstanding under the 2002 Plan or the 2005 Plan and pursuant to the provisions of the 2002 Plan and the 2005 Plan, the Company’s board of directors terminated the 2002 Plan and the 2005 Plan.




Item 2.   Management’s Discussion and Analysis of Financial Statements and Results of Operations


This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are based on our management’s beliefs and assumptions and on information currently available to them.  For this purpose any statement contained in this report that is not a statement of historical fact may be deemed to be forward-looking, including statements about our revenue, spending, cash flow, products, new customer acquisitions, trends, actions, intentions, plans, strategies and objectives.  Without limiting the foregoing, words such as “may,” “hope,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “project,” “intend,” “budget,” “plan,” “forecast,” “predict,” “could,” “should,” or “continue” or comparable terminology are intended to identify forward-looking statements.  These statements by their nature involve substantial risksrisk and uncertainty, and actual results may differ materially depending on a variety of factors, many of which are not within our control.  These factors include but are not limited to economic conditions generally and in the industry in which we and our customers participate; cost reduction efforts by our existing and prospective customers; competition within our industry, including competition from much larger competitors; business combinations; legislative requirements or changes which could render our services less competitive or obsolete; our failure to successfully develop new services, and/or products or to anticipate current or prospective customers’ needs; our ability to retain existing customers and to attract new customers; price increases; employee limitations; and delays, reductions, or cancellations of contracts we have previously entered.


Forward-looking statements are predictions and not guarantees of future performance or events.  Forward-looking statements are based on current industry, financial and economic information, which we have assessed but which, by its nature, is dynamic and subject to rapid and possibly abrupt changes.  Our actual results could differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business.  We hereby qualify all our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of their dates and should not be relied upon.  We undertake no obligation to publicly update or revise any forward-looking statements whether as a result of new information, future events or otherwise (other than pursuant to reporting obligations imposed on registrants pursuant to the Exchange Act) to reflect subsequent events or circumstances.


The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes contained elsewhere in this report and in our other filings with the Commission.


Throughout this quarterly report on Form 10-Q, unless the context indicates otherwise, the terms, “we,” “us,” “our” or “the Company” refer to Pacific Health Care Organization, Inc., (“PHCO”) and our wholly-owned subsidiaries Medex Healthcare, Inc. (“Medex”), Industrial Resolutions Coalition, Inc. (“IRC”), Medex Managed Care, Inc. (“MMC”), Medex Medical Management, Inc. (“MMM”) and Medex Legal Support, Inc., (“MLS”).


Overview


We are workers’ compensation cost containment specialists.  Our business objective is to deliver value to our clients that reduces their workers’ compensation related medical claims expense in a manner that will assure that injured employees receive high quality healthcare that allows them to recover from injury and return to gainful employment without undue delay.  According to studies conducted by auditing bodies on behalf of the California Division of Workers’ Compensation, (“DWC”) the two most significant cost drivers for workers’ compensation are claims frequency and medical treatment costs.


Our core service focuses on the reduction of medical treatment costs by enabling our client/employers to share the control over the medical treatment process.  This control is obtained by participation in one of our medical treatment networks.  We hold several valuable government-issued licenses to operate medical treatment networks.  Through Medex we hold two of the total of nine licenses issued by the State of California to establish and manage a Health Care Organization (“HCO”) within the state of California. We also hold approvals issued by the State of California to act as a Medical Provider Network (“MPN”).  Our HCO and MPN programs provide our client/employers with provider networks within which the client/employer has some ability to direct the administration of the claim.  This is designed to decrease the incidence of fraudulent claims and disability awards and ensure injured employees receive the necessary back-to-work rehabilitation and training they need.  We also offer a Nurse Case Management program that keeps medical treatment claims progressing to a resolution and assures treatment plans are aligned from a medical perspective.  Nurse oversight is a collaborative process that assesses plans, implements, coordinates, monitors and evaluates the options and services required to meet an injured worker’s health needs


needs.

Our clients include self-administered employers, insurers, third party administrators, municipalities and others.  Our principal clients are located in the State of California where the high cost of workers’ compensation insurance is a critical problem for employers.  Our networks have contracted with approximately 3,900 individual medical providers and clinics, as well as hospitals, pharmacies, rehabilitation centers and other ancillary services enabling our networks to provide comprehensive medical services throughout California.  Our provider networks are composed of experts in treating worker injuries. 


Beyond the core services we provide to facilitate client/employers’employer’s involvement in employee medical treatment claims administration and patient treatment options, we also provide to our HCO and MPN clients severala number of claims-related services that bring efficiencies to claim processing and management that further reduce the overall burden of workers’ compensation claims resolution.  These services include various back office type functions that assure cost efficiency and accuracy in claim processing, claim reimbursement and claim dispute resolution.


Results of Operations


Comparison of the three months ended September 30, 2018 and 2017

The following represents selected components of our consolidated results of operations, for the three-month periodperiods ended March 31,September 30, 2018 and 2017, respectively, together with changes from period-to-period:

  

For three months ended September 30,

         
  

2018

  

2017

  

Amount Change

  

% Change

 

Revenues:

                

HCO fees

 $372,664  $377,923  $(5,259

)

  -1

%

MPN fees

  128,113   142,257   (14,144

)

  -10

%

NCM fees

  624,655   582,544   42,111   7

%

UR fees

  327,744   277,886   49,858   18

%

MBR fees

  140,084   147,094   (7,010

)

  -5

%

Other

  83,049   73,203   9,846   13

%

Total revenues

  1,676,309   1,600,907   75,402   5

%

                 

Expense:

                

Depreciation and amortization

  17,412   19,462   (2,050

)

  -11

%

Bad debt provision

  -   15,750   (15,750

)

  -100

%

Consulting fees

  91,619   90,079   1,540   2

%

Salaries and wages

  644,407   547,963   96,444   18

%

Professional fees

  91,080   109,064   (17,984

)

  -16

%

Insurance

  73,042   79,489   (6,447

)

  -8

%

Outsource service fees

  92,122   146,287   (54,165

)

  -37

%

Data maintenance

  16,661   12,160   4,501   37

%

General and administrative

  209,156   162,164   46,992   29

%

Total expenses

  1,235,499   1,182,418   53,081   4

%

                 

Income from operations

  440,810   418,489   22,321   5

%

                 

Income before taxes

  440,810   418,489   22,321   5

%

Income tax provision

  123,734   174,560   (50,826

)

  -29

%

                 

 Net income

 $317,076  $243,929  $73,147   30

%

10

  For three months ended March 31, 
  2018  2017  Amount Change  % Change 
       
Revenues:            
HCO fees $399,442  $302,569  $96,873   32%
MPN fees  134,644   138,281   (3,637)  (3%)
NCM fees  582,569   587,236   (4,667)  (1%)
UR fees  287,021   237,045   49,976   21%
MBR fees  114,039   156,778   (42,739)  (27%)
Other  65,594   119,347   (53,753)  (45%)
Total revenues  1,583,309   1,541,256   42,053   3%
                 
Expense:                
Depreciation  16,344   19,827   (3,483)  (18%)
Bad debt provision  -   (3,250)  3,250   100%
Consulting fees  78,814   77,260   1,554   2%
Salaries and wages  491,478   588,657   (97,179)  (17%)
Professional fees  77,470   82,084   (4,614)  (6%)
Insurance  67,029   87,275   (20,246)  (23%)
Outsource service fees  95,881   112,748   (16,867)  (15%)
Data maintenance  32,431   34,619   (21,188)  (6%)
General and administrative  168,205   161,388   6,817   4%
Total expenses  1,027,652   1,160,608   (132,956)  (11%)
                 
Income from operations  555,657   380,648   175,009   46%
                 
                 
Income before taxes  555,657   380,648   175,009   46%
Income tax provision  155,976   158,391   (2,415)  (2%)
                 
 Net income $399,681  $222,257  $177,424   80%

Revenue


Total revenues during the three-month period ended March 31,September 30, 2018, increased 3%5% to $1,583,309$1,676,309 compared to $1,541,256$1,600,907 during the three-month period ended March 31,September 30, 2017.


During the firstthird quarter 2018, HCOnurse case management, utilization review, and URother fees increased 32%7%, 18%, and 21%,13% respectively, while MPN, MBR, NCMHCO, and other revenuemedical bill review decreased by 3%, 27%10%, 1% and 45%5%, respectively.  Other revenues consisted of revenues derived primarily from network claims repricing services, lien representation services, legal support services, workers’ compensation carve out revenues and Medicare-set-asideMedicare set-aside revenues.


HCO fees


During the three-month periods ended March 31,September 30, 2018 and 2017, HCO fee revenues were $399,442$372,664 and $302,569$377,923, respectively.  The 32%1% decrease in HCO revenue was primarily attributable to the loss of a customer at the end of our first quarter of 2018.

MPN fees

MPN fee revenue for the three-month periods ended September 30, 2018 and 2017, were $128,113 and $142,257, respectively, a decrease of 10%, due to the loss of one customer at the beginning of our fourth quarter of 2017 and one customer at the end of our first quarter of 2018.

NCM fees

During the three months ended September 30, 2018 and 2017, nurse case management revenue was $624,655 and $582,544, respectively.  The increase in nurse case management revenue of $42,111 was primarily from a new customer and the hiring of additional nurse case managers to handle more claims.

UR fees

During the three-month periods ended September 30, 2018 and 2017, utilization review revenue was $327,744 and $277,886, respectively.  The increase of $49,858 in the 2018 period was primarily attributable to the increase in utilization review referrals from existing customers and the addition of two new customers.

MBR fees

During the three-month period ended September 30, 2018, medical bill review revenue decreased $7,010 to $140,084 when compared to the same period a year earlier. This decrease was mainly caused by processing fewer hospital bills from existing customers. We believe this decrease in hospital bill reviews is principally the result of the implementation of hospital fee schedules. Many of our existing customers have elected to pay the fee schedule, as opposed to having us review their hospital bills. Medical bill review involves analyzing medical provider services and equipment billing to ascertain proper reimbursement. Such services include, but are not limited to, coding review and re-bundling, confirming that the services are customary and reasonable, fee schedule compliance, out-of-network bill review, pharmacy review, and preferred provider organization repricing arrangements. Our medical bill review services can result in significant network savings. 

Other

Other fees consist of revenue derived from network access and claims repricing, lien representation, legal support services, Medicare set-aside and workers’ compensation carve-out services.  Other fee revenue for three-month periods ended September 30, 2018 and 2017, were $83,049 and $73,203, respectively. The increase of $9,846 was the result of current clients referring more Medicare set-asides to be processed. We recorded no carve-out, lien representation, or legal support services during the three-month period ended September 30, 2018.

Expenses

Total expenses for the three months ended September 30, 2018 and 2017, were $1,235,499 and $1,182,418, respectively.  The increase of $53,081 was the result of increases in consulting fees, salaries and wages, data maintenance expense, and general and administrative expense partially offset by decreases in depreciation and amortization, bad debt provision, professional fees, insurance and outsource service fees.

Depreciation and Amortization

During the three-month period ended September 30, 2018, we recorded depreciation and amortization expense of $17,412 compared to $19,462 during the comparable 2017 period.  The decrease in depreciation and amortization was primarily attributable to certain fixed assets being fully depreciated during the three-months ended September 30, 2018.

Bad Debt Provision

During the three-month period ended September 30, 2018, bad debt provision decreased to $0 from $15,750 during the three-month period ended September 30, 2017.  This decrease was primarily the result of clients paying certain invoices that were outstanding over 90 days during fiscal 2018.

Consulting Fees

During the three months ended September 30, 2018, consulting fees increased to $91,619 from $90,079 during the three months ended September 30, 2017. This increase was primarily the result of a net increase in consulting fees resulting from hiring a new consultant. This expense was partially offset by the termination of another consultant.

Salaries and Wages

During the three-month period ended September 30, 2018, salaries and wages increased 18% to $644,407 compared to $547,963 during the same period in 2017. The increase in salaries and wages of $96,444 was primarily the result of hiring a Director of Healthcare and other employees for various departments.

Professional Fees

For the three months ended September 30, 2018, we incurred professional fees of $91,080 compared to $109,064 during the three months ended September 30, 2017.  The $17,984 decrease in professional fees was primarily the decrease in medical consultant fees partially offset by a net increase in other professional fees.

Insurance

During the three-month period ended September 30, 2018, we incurred insurance expenses of $73,042, an 8% decrease over the same three-month period in 2017.  This decrease in insurance expense was primarily attributable to lower group health insurance premiums when compared to the same period in 2017 because we had fewer employees in the 2018 period. We do not expect current insurance fees to increase significantly over the remaining months of 2018.

Outsource Service Fees

Outsource service fees consist of costs incurred by our subsidiaries in outsourcing utilization review, medical bill review, Medicare set-aside services and field case management fees and typically tends to increase and decrease in correspondence with increases and decreases in demand for those services.  We incurred $92,122 and $146,287 in outsource service fees during the three-month periods ended September 30, 2018 and 2017, respectively.  The decrease of $54,165 was primarily the result of decreases in outsource services required for utilization review, medical bill review and nurse case management.  We anticipate our outsource service fees will continue to move in correspondence with the level of utilization review, medical bill review and certain nurse case management services we provide in the future.  

Data Maintenance

During the three-month periods ended September 30, 2018 and 2017, data maintenance fees were $16,661 and $12,160, respectively.  The increase of $4,501 was primarily the result of higher levels of customer notification fees realized for new and existing customers during the three-month period ended September 30, 2018 when compared to the same period in 2017.  Data maintenance fees tend to fluctuate from month to month depending on when new customers are enrolled, when the annual renewal of existing customer notification is due, and how many new employees our customers enroll in our HCO or MPN program.

General and Administrative

During the three-month period ended September 30, 2018, general and administrative expenses increased 29% to $209,156 when compared to the three-month period ended September 30, 2017.  This increase of $46,992 was primarily attributable to increases in auto expense, dues and subscriptions, licenses and permits, parking, rent-expense equipment, rent expense, and transfer agent fees partially offset by decreases in IT enhancement, postage and delivery, and travel and entertainment. We do not expect current levels of general and administrative expenses to materially increase during the remaining months of 2018.

Income from Operations

As a result of the 5% increase in total revenue during the three-month period ended September 30, 2018, which was partially offset by the 4% increase in total expenses during the same period, our income from operations increased by 5% during the three-month period ended September 30, 2018, when compared to the same period in 2017. 

Income Tax Provision

We realized income before taxes of $440,810 and $418,489 during the three-month periods ended September 30, 2018 and 2017, respectively. However, we realized a $50,826, or 29%, decrease in our income tax provision. The lower provision of income taxes was the result of implementing the lower corporate tax rate at the beginning of fiscal 2018 partially offset by higher income taxes resulting from the increase in income before taxes.

Net Income

During the three-month period ended September 30, 2018, total revenues of $1,676,309 was 5% higher when compared to the same period in 2017.  This increase in total revenues was partially offset by a 4% increase in total expenses, resulting in a 5% increase in income from operations compared to the three months ended September 30, 2017.  Correspondingly, we realized net income of $317,076 for the three-month period ended September 30, 2018, which reflects a 30% increase compared to the three-month period ended September 30, 2017. 

Comparison of nine months ended September 30, 2018 and 2017

The following represents selected components of our consolidated results of operations, for the nine-month periods ended September 30, 2018 and 2017, respectively, together with changes from period-to-period:

  

For nine months ended September 30,

         
  

2018

  

2017

  

Amount Change

  

% Change

 

Revenues:

                

HCO fees

 $1,132,371  $1,041,328  $91,043   9

%

MPN fees

  393,390   427,228   (33,838

)

  -8

%

NCM fees

  1,822,826   1,824,121   (1,295

)

  -0

%

UR fees

  914,262   788,229   126,033   16

%

MBR fees

  380,293   481,352   (101,059

)

  -21

%

Other

  277,993   255,542   22,451   9

%

Total revenues

  4,921,135   4,817,800   103,335   2

%

                 

Expense:

                

Depreciation and amortization

  50,199   58,859   (8,660

)

  -15

%

Bad debt provision

  (35,000

)

  30,500   (65,500

)

  -215

%

Consulting fees

  255,882   246,073   9,809   4

%

Salaries and wages

  1,763,235   1,734,321   28,914   2

%

Professional fees

  246,293   308,295   (62,002

)

  -20

%

Insurance

  213,242   257,495   (44,253

)

  -17

%

Outsource service fees

  351,962   404,538   (52,576

)

  -13

%

Data maintenance

  65,890   71,261   (5,371

)

  -8

%

General and administrative

  560,928   495,474   65,454   13

%

Total expenses

  3,472,631   3,606,816   (134,185

)

  -4

%

                 

Income from operations

  1,448,504   1,210,984   237,520   20

%

                 

Income before taxes

  1,448,504   1,210,984   237,520   20

%

Income tax provision

  406,593   504,318   (97,725

)

  -19

%

                 

Net income

 $1,041,911  $706,666  $335,245   47

%

Revenue

Total revenues during the nine-month period ended September 30, 2018, increased 2% to $4,921,135 compared to $4,817,800 during the nine-month period ended September 30, 2017.

During the first nine-months of 2018, HCO, utilization review, and other revenue increased 9%, 16% and 9% respectively, while MPN and medical bill review decreased by 8% and 21%, respectively.  NCM revenue was slightly lower.  Other revenues consisted of revenues derived primarily from network claims repricing services, lien representation services, legal support services, workers’ compensation carve-out revenues and Medicare set-aside revenues.

HCO fees

During the nine-month periods ended September 30, 2018 and 2017, HCO fee revenues were $1,132,371 and $1,041,328 respectively. The 9% increase in HCO revenue was primarily attributable to adding two newincreases by one major client, partially offset by lower revenues from several existing HCO customers increased employee enrollment and rate increaseswhen compared to the same period in program administration services.2017.


MPN fee revenue for the three-monthnine-month periods ended March 31,September 30, 2018 and 2017, was $134,644$393,390 and $138,281,$427,228 respectively, a decrease of 3%8%, resulting from one customer phasing out its business through bankruptcy. 


the loss of two customers and decreases in revenue from others. 

NCM fees


During the three monthsnine-months ended March 31,September 30, 2018 and 2017, nurse case management revenue was $582,569$1,822,826 and $587,236,$1,824,121, respectively.  The decrease in nurse case management revenue of $4,667$1,295 was primarily the result of losing a net decreasecustomer during our first quarter 2018 which was partially offset by increases in case management activity duringrevenues from existing customers and gaining one new customer.  As a result of losing a significant customer in the first quarter 2018, there is no assurance that nurse case management revenue will decrease at the rate realized during the nine months ended September 30, 2018, for the remainder of 2018 when compared to the same period in 2017.


fiscal 2018.

UR fees


During the three-monthnine-month periods ended March 31,September 30, 2018 and 2017, utilization review revenue was $287,021$914,262 and $237,045,$788,229, respectively.  The increase of $49,976$126,033 in the 2018 period was primarily attributable to increased utilization reviewsvolume from existing customers and the addition of two major customers.new customers in third quarter 2018. Utilization review can provide a safeguard against unnecessary and inappropriate medical treatment from the perspective of medical necessity, quality of care, appropriateness of decision-making, etc. Through our skilled staff and automated review system, we are able to deliver utilization review services that cut overhead costs for the self-insured clients, insurance companies and the public entities we service. 


MBR fees


During the three-monthnine-month period ended March 31,September 30, 2018, medical bill review revenue decreased $42,739$101,059 to $114,039$380,293 when compared to the same period a year earlier.  This 21% decrease was mainly caused by terminationsprocessing fewer hospital bills from existing customers. As mentioned above, we believe this decrease in hospital bill reviews is principally the result of threethe implementation of hospital fee schedules. Many of our existing customers during fiscal 2017.  Medical bill review involves analyzing medical provider services and equipment billinghave elected to ascertain proper reimbursement.  Such services include, but are not limited to, coding review and rebundling, confirming thatpay the services are customary and reasonable, fee schedule, compliance, out-of-network billas opposed to having us review pharmacy review, and preferred provider organization repricing arrangements.  These services can result in significant network savings. 


their hospital bills.

Other


Other fees consist of revenue derived from network access and claims repricing, lien representation, legal support services, Medicare-set-asideMedicare set-aside and workers’ compensation carve-outscarve-out services.  Other feefees revenue for three-monthnine-month periods ended March 31,September 30, 2018 and 2017, was $65,594were

$277,993 and $119,347,$255,542, respectively. The decreaseincrease of $53,753$22,451 was primarily the result of lower levels of network access revenuesincreased Medicare set-aside referrals. We did not record any revenue for lien representation, legal support services, and the loss of one major customer.


workers’ compensation carve-out services.

Expenses

Total expenses for the three monthsnine-months ended March 31,September 30, 2018 and 2017, were $1,027,652$3,472,631 and $1,160,608,$3,606,816, respectively.  The decrease of $132,956$134,185 was the result primarily of lowerdecreases in depreciation, bad debt, professional fees, insurance, outsource service fees and data maintenance, partially offset by increases in consulting fees, salaries and wages professional fees, insurance expense and outsource servicegeneral and administrative fees.


Depreciation and Amortization


During the three-monthnine-month period ended March 31,September 30, 2018, we recorded depreciation and amortization expense of $16,344$50,199 compared to $19,827$58,859 during the comparable 2017 period.  The decrease in depreciation and amortization was primarily attributable to certain fixed assets being fully depreciated during the last nine months of 2017 and the first quarter ofnine-months ended September 30, 2018.


Bad Debt


Provision

During the three-monthnine-month period ended March 31,September 30, 2018, we did not record any bad debt provision which resulted in our allowance for bad debt allowance remaining at $60,150 fordecreased by $65,500 compared to the nine-month period ended March 31, 2018 and 2017.


Consulting Fees

During the three months ended March 31, 2018, consulting fees increased to $78,814 from $77,260 during the three months ended March 31, 2017.   This increase of $1,554 was the result of an increase in fees paid to one consultant during the first quarter of 2018.

Salaries and Wages

During the three-month period ended March 31, 2018, salaries and wages decreased 17% to $491,478 compared to $588,657 during the same period inSeptember 30, 2017.  This decrease was primarily the result of various delinquent customers making payments which resolved their uncollectible status.

Consulting Fees

During the net terminationnine-months ended September 30, 2018, consulting fees increased to $255,882 from $246,073, when compared the nine months ended September 30, 2017.   This 4% increase was mainly the result of six employees from April 2017hiring a consultant to March 2018. We employed 33assist us in our merger and 39 full-time employees asacquisition strategies.

Salaries and Wages

During the nine-month period ended September 30, 2018, salaries and wages increased 2% to $1,763,235 compared to $1,734,321 during the same period in 2017. This increase was primarily the result of March 31,additional staffing in nurse case management, HCO, MPN, and on July 1, 2018, and 2017, respectively.


we reinstated the senior executive 10% salary reductions implemented in June 2016.

Professional Fees


For the three monthsnine-months ended March 31,September 30, 2018, we incurred professional fees of $77,470,$246,293 compared to $82,084$308,295 during the threenine months ended March 31,September 30, 2017.   The $4,614 decrease of $62,002 in professional fees was mainlyprimarily the result of decreased professionallower fees paid for accounting, legal, and nurse case management services, partially offset by fee increasesincreased fees for medical consulting and other fees related to our medical consultant.


Medicare set-asides.

Insurance


During the three-monthnine-month period ended March 31,September 30, 2018, we incurred insurance expenses of $67,029,$213,242, a 23%17% decrease over the same three-monthnine-month period in 2017.  The decrease in insurance expense was primarily attributed to lower workersworkers’ compensation premiums for our employees and directorlower directors’ and officer’sofficers’ insurance premiums during the first three months ofnine-month period ended September 30, 2018 compared to the same period in 2017. We do not expect current insurance fees to moderately increase significantly over the remaining months of 2018.


Outsource Service Fees


Outsource service fees consist of costs incurred by our subsidiaries in outsourcing utilization review, medical bill review, andMedicare set-aside services, field nurse case management services, and typically tends to increase and decreasefluctuate in correspondence with increases and decreases in demand for those services.  

We incurred $95,881$351,962 and $112,748$404,538 in outsource service fees during the three-monthnine-month periods ended MarchSeptember 2018 and 2017, respectively.  The decrease of $16,867$52,576 was primarily the result of decreases in outsource services required for Medicare-set-aside, NCM and MBR, partially offset by increases in UR.field nurse case management fees.  We anticipate our outsource service fees will continue to move in correspondence with the level of utilization review, medical bill review and certain nurse case management services we provide in the future.  


Data Maintenance


During the three-monthnine-month period ended March 31,September 30, 2018 and 2017, data maintenance fees were $32,431$65,890 and $34,619,$71,261, respectively. The decrease of $2,188$5,371 was primarily the result of recording lower levels of notification fees associated withlosing a customer’s annual renewalmajor customer, which was partially offset by increases in data maintenance by other existing customers during the three-monthnine-month period ended March 31,September 30, 2018.

General and Administrative

During the nine-month period ended September 30, 2018, general and administrative expense increased 13% to $560,928 when compared to the same period in 2017.


General and Administrative
During the three-monthnine-month period ended March 31, 2018, general and administrative expenses increased 4% to $168,205 when compared to the three-month period ended March 31,September 30, 2017.  This increase of $6,817$65,454 was primarily attributable to increases in auto expense, bank charges, dues and subscriptions, education expense, employment agency fees, licenses and permits, telephone officeexpense, rent IT enhancement, office rent and shareholders expense, partially offset by decreases in charitable contributions, IT enhancement, postage, travel and entertainment expense, and miscellaneous general and administrative expenses.expense. We do not expect current levels of general and administrative expenses to materially increase during the remaining months of 2018, providing revenues continue to also increase.

2018.

Income from Operations


As a result of the 3%2% increase in total revenue during the three-monthnine-month period ended March 31,September 30, 2018, togethercoupled with an 11%a 4% decrease in total expenses, our income from operations before taxes increased by 46% whento $1,448,504 a 20% increase compared to the same quarterperiod in 2017.


Income Tax Provision


We realized income before taxes of $555,657$1,448,504 and $380,648$1,210,984 during the three-monthnine-month periods ended March 31,September 30, 2018 and 2017, respectively.  AsHowever, as a result of Federal and State incomeimplementing the lower corporate tax reductionsrate at the beginning of approximately 13%fiscal 2018 we realized a $2,415,$97,725, or 2%19%, decrease in our income tax provision. 


Net Income


During the three-monthnine-month period ended March 31,September 30, 2018, total revenues of $1,583,309$4,921,135 was 3%2% higher when compared to the same period in 2017.  This increase in total revenues together with a decrease of 4% in total expenses of 11% resulted in a 46%20% increase in income from operations compared to the three months ended March 31, 2017.operations.  Correspondingly, we realized net income of $399,681$1,041,911 for the three-monthnine-month period ended March 31,September 30, 2018, an 80%a 47% increase compared to the three-monthnine-month period ended March 31,September 30, 2017. 

Liquidity and Capital Resources


As of March 31,September 30, 2018, we had cash on hand of $6,705,681$6,846,162 compared to $5,815,071 at December 31, 2017.  The $890,610$1,031,091 increase was primarily the result of net cash provided by our operating activities, partially offset by cash used in investing activities and financing activities. NetThe increase in cash provided by ourflow from operating activities was primarily the result of realizingincreases in net income, coupled with increases in accumulated depreciation and amortization, income tax payablecredit card payables, accrued expenses and unearned revenue and decreasesa decrease in accounts receivable and unearned revenues, partially offset by increases in prepaid expense and decreases in accruedbad debt provision, income tax payable, deferred rent expenses, accounts payable and deferred rent.increases in prepaid expenses and prepaid income tax. We used $2,988$30,418 in investing activities for purchases ofto purchase computers, furniture and equipment.  Cash for financing activities of $19,923 was used to issue cash dividends previously authorized by the Company.  Barring a significant downturn in the economy or the loss of major customers, we believe that cash on hand and anticipated revenues from operations will be sufficient to cover our operating expenses over the next twelve months.


We currently have planned certain capital expenditures during 2018, to expand our IT capabilities.  We believe we have adequate capital on hand to cover these expenditures and do not anticipate this will require us to seek outside sources of funding.  


We continue to investigate potential opportunities to expand our business either through the creation of new business lines or the acquisition of existing businesses.  We are also looking to expand our business into the insurance industry during 2018, but have not identified anyindustry. We are actively conducting a search to for a suitable merger or acquisition candidates or opportunities atinsurance company to acquire.  At the current time.  Wetime, there is no assurance we can identify a suitable candidate or negotiate acceptable terms of an acquisition.  If we do find a suitable acquisition candidate, we anticipate an expansion or acquisition of this sort maywill require greater capital resources than we currently possess.  Should we need additional capital resources, we couldpossess, which would likely require us to seek to obtain such through debt and/or equity financing.  We do not currently possess an institutional source of financing and there is no assurance that we could be successful in obtaining equity or debt financing when needed on favorable terms, or at all.  We could also use shares of our capital stock as consideration for a business acquisition transaction.  The use of our capital stock either for an equity financing or as consideration for an acquisition could lead to substantial dilution to our existing shareholders.


During the threenine months ended March 31,September 30, 2018, cash was primarily used to fund operations. We had a net increase in cash of $890,610$1,031,091 during the threenine months ended March 31, 2018, compared to a net increase of $81,340 during the three months ended March 31, 2017.September 30, 2018.  See below for additional information.


  For the three months ended March 31, 
  
2018
(unaudited)
  
2017
(unaudited)
 
       
Net cash provided by operating activities $893,598  $87,094 
Net cash used in investing activities  (2,988)  (5,754)
Net cash used in financing activities  -   - 
         
Net increase in cash $890,610  $81,340 

  

For the nine months ended September

 
  

2018

(unaudited)

  

2017

(unaudited)

 
         

Net cash provided from operating activities

 $1,081,432  $621,241 

Net cash used in investing activities

  (30,418

)

  (13,446

)

Net cash used in financing activities

  (19,923

)

  - 
         

Net increase in cash

 $1,031,091  $607,795 

During the threenine months ended March 31,September 30, 2018 and 2017, net cash provided by operating activities was $893,598$1,081,432 and $87,094,$621,241, respectively.  As discussed herein, we realized net income of $399,681$1,041,911 during the threenine months ended March 31,September 30, 2018, compared to net income of $222,257$706,666 during the threenine months ended March 31,September 30, 2017.  The increase of $806,504 in cash flow from operating activities was primarily the result of increases in net income, accumulated depreciation and amortization, income tax payable, unearned revenue, and decreases in accounts receivable, partially offset by increases in prepaid expense and decreases in accounts payable, accrued expenses, and deferred rent expense.


Net cash used in investing activities was $2,988$30,418 and $5,754$13,446 during the three-monthnine-month periods ended March 31,September 30, 2018 and 2017, respectively.  NetDuring the nine-month periods ended September 30, 2018 and 2017, net cash used in investing activities was lower by $2,766used to purchase computer equipment, furniture and office equipment.

Net cash used in financing activities during the three-monthnine-month periods ended September 30, 2018 and 2017 was $19,923 and $0, respectively. During the 2018 period ended March 31, 2018, becausecertain shareholders submitted the necessary paperwork to receive payment of lower expenditures for computers, furniture, and equipment.


the cash dividend declared on their shares in 2015. We received no similar requests during the 2017 period.

Summary of Material Contractual Commitments


The following is a summary of our material contractual commitments as of March 31,September 30, 2018.


  Payments Due By Period 
  Total  Less than 1 year  1-3 years  3-5 years  More than 5 years 
Operating Leases:               
Operating Leases – Equipment(1)
 $46,519  $20,675  $25,844  $-  $- 
Office Leases(2)
 $1,031,400   255,608   775,792   -   - 
Total Operating Leases $1,077,919  $276,283  $801,636  $-  $- 
(1)In March 2017, we entered a 39-month operating lease for an office copy machine with scanner with monthly payment at $1,723, commencing in April 2017.
(2)In July 2015, we entered a 79-month lease to lease approximately 9,439 square feet of office space that commenced in September 2015.  This office space serves as our principal executive offices, as well as, the principal offices of our operating subsidiaries.

  

Payments Due By Period

 
  

Total

  

Less than 1 year

  

1-3 years

  

3-5 years

  

More than 5 years

 

Operating Leases:

                    

Operating Leases – Equipment

 $36,182  $20,675  $15,507  $-  $- 

Office Leases

 $903,973   238,146   665,827   -   - 

Total Operating Leases

 $940,155  $258,821  $681,334  $-  $- 

Off-Balance Sheet Financing Arrangements


As of March 31,September 30, 2018, we had no off-balance sheet financing arrangements.


Inflation


We experience pricing pressures in the form of competitive prices.  We are also impacted by rising costs for certain inflation-sensitive operating expenses such as labor and employee benefits and facility leases.  However, we generally do not believe these impacts are material to our revenues or net income.


Critical Accounting Policies and Estimates


See Note 1 to our condensed consolidated financial statements included elsewhere in this report.

Item 3.  Quantitative and Qualitative Disclosure about Market Risk

This information is not required for smaller reporting companies.


Item 4.   Controls and Procedures


Evaluation of Disclosure Controls and Procedures


We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, which are controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.


Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, conducted an evaluation the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q.  Based on the evaluation of our disclosure controls and procedures as of March 31,September 30, 2018, the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level.


Changes in Internal Control over Financial Reporting


There were no changes in our internal control over financial reporting during the quarter ended March 31,September 30, 2018, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.


PART II.   OTHER INFORMATION


Item 1A.  Risk Factors


Management does not believe there have been any material changes to the risk factors listed in Part I, “Item 1A, Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2017.  These risk factors should be carefully considered with the information provided elsewhere in this report, which could materially adversely affect our business, financial condition or results of operations.


Item 5.Other Events

As disclosed in more detail in Note 2 to the Condensed Consolidated Financial Statements to this Quarterly Report on Form 10-Q, on April 5, 2018, the Forward Split became effective.  As a result, the number of authorized shares of our common stock increased from 50,000,000 shares to 200,000,000 shares, our outstanding common stock increased from 800,000 shares to 3,200,000 shares and our outstanding Series A Preferred Stock increased from 1,000 shares to 4,000 shares.  The number of shares available for issuance under our 2002 Plan and our 2005 Plan, as well as all awards outstanding under those plans also increased at the same four-shares-for-one-share ratio, and the exercise prices of stock options outstanding at the time of the Forward Split were adjusted to reflect the Forward Split.  On April 6, 2018, the date immediately following the effective date of the Forward Split, the 2018 Plan became effective.

On May 14, 2018, we entered into the Cancellation Agreements with certain executive officers, directors and other senior level employees/consultants of the Company, pursuant to which such Optionholders agreed to the surrender and cancellation of certain previously granted stock options to purchase shares of the Company’s common stock pursuant to our 2002 Plan and our 2005 Plan.  Under the terms of the Cancellation Agreements, each Optionholder and the Company acknowledged and agreed that the surrender and cancellation of the Cancelled Options was without any expectation on the part of the Optionholder to receive, and without any obligation on our part to pay or grant, any cash, equity awards or other consideration presently or in the future with respect to the Cancelled Options.
The executive officers and directors that entered into Cancellation Agreements and the aggregate number of shares of our common stock underlying the Cancelled Options surrendered by each such officer and/or director are as follows:

  Cancelled Option Amount 
Name of Optionholder Pre-Forward Split  Post-Forward Split 
Tom Kubota
  50,000   200,000 
Fred Odaka  11,000   44,000 
Kristina Kubota  1,000   4,000 
Lauren Kubota  1,000   4,000 

Two senior level employees/consultants of the Company surrendered Cancelled Options covering a total of 22,000 pre-Forward Split (88,000 post-Forward Split) shares.

The foregoing description of the Cancellation Agreements is qualified by reference to the full text of the Stock Option Cancellation Agreement, the form of which is filed herewith as Exhibit 99.1 to this Quarterly Report on Form 10-Q and is incorporated herein by reference.

Following the surrender and cancellation of the Cancelled Options there were no awards outstanding under the 2002 Plan or the 2005 Plan and pursuant to the provisions of the 2002 Plan and the 2005 Plan, our board of directors terminated the 2002 Plan and the 2005 Plan.

Item 6.   Exhibits

Exhibits.  The following exhibits are filed or furnished, as applicable, as part of this report:

Exhibit Number

Title of Document

Exhibit 4.1

Exhibit 31.1

Exhibit 31.2

Exhibit 32.1

Exhibit 99.1

Exhibit 101

The following materials from Pacific Health Care Organization, Inc.’s Quarterly Report on Form 10-Q for the period ended March 31,September 30, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) the Unaudited Condensed Consolidated Balance Sheets, (ii) the Unaudited Condensed Consolidated Statements of Operations, (iii) the Unaudited Condensed Consolidated Statements of Cash Flows, and (iv) Notes to the Unaudited Condensed Consolidated Financial Statements.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PACIFIC HEALTH CARE ORGANIZATION, INC.

Date:

May 15,

November 14, 2018

/s/ Tom Kubota

Tom Kubota

Chief Executive Officer


Date:

May 15,

November 14, 2018

/s/ Fred Odaka

Fred Odaka

Chief Financial Officer


18